EXTH-23. COMBINED EFFECTS OF NICLOSAMIDE AND TEMOZOLOMIDE AGAINST HUMAN GLIOBLASTOMA TUMORSPHERES

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Cheol Oh, Hyeong, Yoo, Jihwan, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-hyun, Joo Choi, Ran, sil Kim, Hyun, hee Kim, Nam, Hyung Moon, Ju, Hyun Kim, Eui, Hee Chang, Jong, Kang, Seok-Gu, In Yook, Jong
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Experimental Therapeutics
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847496/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.357
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg